Nightingale as an investment
Financial information
Share and shareholders
Governance
- Governance principles
- General Meeting
- Annual General Meeting 2025
- Board of Directors
- Management Team
- Remuneration
- Risk management
- Insider management
- Managers' transactions
- Flagging notifications
- Auditor
- Articles of Association
- Code of Conduct
- Stock Exchange Releases
- Company releases
- Press releases
- Managers' transactions
- Flagging notifications
- En
- Fi
Company releases
- Conversion of Nightingale Health Plc’s EMP shares to Series B shares - Dec 23, 2024
- Nightingale Health Plc appoints Lago Kapital as liquidity provider - Dec 18, 2024
- Nightingale Health Plc: Subscription of Series B shares with option rights - Dec 13, 2024
- Inside information: Nightingale Health is investigating the transfer of its B shares to the Main Market of Nasdaq Helsinki and adding the OTCQX market as an additional trading venue in the U.S. - Nov 27, 2024
- Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health Plc - Nov 08, 2024
- Conversion of Nightingale Health Plc’s Series A shares to Series B shares - Oct 09, 2024
- Nightingale Health’s Board of Directors resolved on amendment to CEO’s incentive program - Sep 20, 2024
- Inside Information: 23andMe and Nightingale Health Announce Strategic Collaboration to Pilot Blood Biomarker Panel - Jun 28, 2024
- Inside information: Nightingale Health and Boston Heart Diagnostics enter strategic partnership to sell Nightingale’s Health Check in the United States - Jun 28, 2024
- Conversion of Nightingale Health Plc’s Series A shares to Series B shares - Jun 11, 2024
- Nightingale Health’s Board of Directors extended the subscription period of employee option rights - May 23, 2024
- Inside information: Nightingale Health achieves one of its business targets for this financial year by winning contracts in medical research with a total contract value of at least EUR 3.2 million - Apr 25, 2024
- Supplement to the release: Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc. - Apr 12, 2024
- Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc. - Apr 12, 2024
- Nightingale Health has completed the acquisition of Welltus Inc - Mar 29, 2024
- Correction: Conversion of Nightingale Health Plc’s EMP shares to Series B shares - Mar 21, 2024
- Conversion of Nightingale Health Plc’s EMP shares to Series B shares - Mar 20, 2024
- Supplement to the release: Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc - Mar 07, 2024
- Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc - Mar 07, 2024
- Change in Nightingale Health Plc’s Management Team - Nov 27, 2023
- Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health Plc - Nov 16, 2023
- Inside information: Nightingale Health and Innoquest Diagnostics enter into collaboration agreement to make Nightingale Health’s technology accessible in the Southeast Asia region - Nov 15, 2023
- Notice to the Annual General Meeting of Nightingale Health Plc - Oct 19, 2023
- Nightingale Health’s Board of Directors resolved on new share-based incentive programs and amendments to existing incentive programs - Oct 16, 2023
- Inside information: Nightingale Health updates its strategy with a focus on B2B and B2G markets - Sep 11, 2023
- Inside information: Terveystalo adopts Nightingale Health’s blood analysis technology in regular health checks in occupational health - Aug 30, 2023
- Conversion of Nightingale Health Plc’s EMP shares to Series B shares - Jul 06, 2023
- Inside information: Update on Nightingale Health Plc’s business targets for financial year 2022 – 2023 - Jul 03, 2023
- Inside information: Nightingale Health and Terveystalo sign letter of intent to expand strategic partnership - Jun 30, 2023
- Nightingale Health Plc’s financial reporting and Annual General Meeting in financial year 2023 – 2024 - May 31, 2023
- Maximilian LeRoux appointed as Chief Commercial Officer of Nightingale Health Plc - May 08, 2023
- Nightingale Health Plc: Resolutions of the Extraordinary General Meeting and the Board of Directors’ organizational meeting - Apr 24, 2023
- Nightingale Health Plc’s Auditor to Change - Mar 24, 2023
- Nightingale Health Plc: Unaudited financial information in accordance with IFRS for the comparative half-year periods - Mar 22, 2023
- Notice to the Extraordinary General Meeting of Nightingale Health Plc - Mar 17, 2023
- Inside information: Nightingale Health acquires worldwide license for blood self-collection device Velvet™ - Jan 31, 2023
- Nightingale Health to open laboratory in the United Kingdom in 2023 - Jan 25, 2023
- Conversion of Nightingale Health Plc’s Series A shares to Series B shares - Dec 22, 2022
- Change in the publication date of Nightingale Health Plc’s half-year financial report for the period 1 July – 31 December 2022 - Nov 17, 2022
- Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health Plc - Nov 17, 2022
- Nightingale Health’s Auditor’s Report for financial year 2021–2022 has been published - Nov 07, 2022
- Nightingale Health Plc: Adoption of International Financial Reporting Standards (IFRS) and unaudited financial information for the comparative period - Oct 27, 2022
- Notice to the Annual General Meeting of Nightingale Health Plc - Oct 14, 2022
- Nightingale Health’s Board of Directors resolved on a change to the share-based incentive schemes - Aug 11, 2022
- Update on Nightingale Health Plc’s business targets for financial year 2021 – 2022 - Jul 05, 2022
- Resolutions of Nightingale Health Plc’s Extraordinary General Meeting - Jun 29, 2022
- Nightingale Health Plc’s financial reporting and Annual General Meeting in financial year 2022 – 2023 - Jun 15, 2022
- Notice to the Extraordinary General Meeting of Nightingale Health Plc - Jun 08, 2022
- Conversion of Nightingale Health Plc’s Series A shares and EMP shares to Series B shares - May 19, 2022
- Nightingale’s Board of Directors resolved on new share-based incentive plans - Mar 18, 2022
- Conversion of Nightingale Health Plc’s Series A shares to Series B shares - Feb 08, 2022
- Nightingale has completed the acquisition of Finnish genetic testing company Negen - Feb 03, 2022
- Nightingale introduces combination of its proprietary blood test and genomics: acquires Finnish genetic testing company Negen and launches international centre of excellence for genomic data analysis - Jan 18, 2022
- Tuukka Paavola appointed as Chief Financial Officer of Nightingale Health Plc - Nov 02, 2021
- Conversion of Nightingale Health Plc’s Series A shares and EMP shares to Series B shares - Oct 29, 2021
- Resolutions of Nightingale Health Plc’s Annual General Meeting and Board of Directors - Oct 28, 2021
- Nightingale and major Finnish pharmacy chain Yliopiston Apteekki enter into nation-wide distribution partnership of Nightingale’s at-home testing solution - Oct 27, 2021
- Nightingale and Terveystalo launch a new well-being membership - Oct 13, 2021
- Notice to the Annual General Meeting of Nightingale Health Plc - Oct 01, 2021
- Jeffrey Barrett appointed as Chief Scientific Officer of Nightingale Health Plc - Aug 30, 2021
- Nightingale Health acquires German digital health company Yolife GmbH - Jul 09, 2021
- Nightingale Health quarterly summary of achieved key milestones and reiteration of near-term business targets - Jul 01, 2021
- Nightingale secures global scalability of its at-home solution by partnering with at-home blood collection device manufacturer Weavr with new commercial terms and minority investment - Jun 29, 2021
- Nightingale successfully completes the first phase of its at-home blood testing pilot - Jun 23, 2021
- Nightingale restructures its Management Team and establishes strategic partnership with Reaktor - May 04, 2021
- Nightingale Health signed service agreement for health and well-being services in Japan - Apr 29, 2021
- Nightingale Health Plc and Terveystalo have entered into strategic partnership agreement - Apr 22, 2021
- Nightingale Health Plc’s subsidiary received clinical laboratory certification in Japan - Apr 09, 2021
- The cancellation of Nightingale Health Plc’s treasury shares entered in the Trade Register - Mar 31, 2021
- Nightingale Health Plc’s ten largest shareholders after the completion of the initial public offering - Mar 25, 2021
- Stabilisation measures taken and the end of the stabilisation period; the Board of Directors has resolved on the cancellation of treasury shares - Mar 23, 2021
- The IPO of Nightingale has been oversubscribed and the listing will be completed as planned – trading in the series B shares is expected to commence on 19 March 2021 - Mar 18, 2021
- Public offering of Nightingale has been oversubscribed and therefore the subscription period has been discontinued - Mar 16, 2021
- Nightingale Health Plc comments on the media coverage on its initial public offering - Mar 15, 2021
- Nightingale has applied for its series B shares to be listed on Nasdaq First North Growth Market Finland and commences the initial public offering - Mar 08, 2021
- Nightingale announces a fixed subscription price and publishes a prospectus for its contemplated IPO and listing of its series B shares on Nasdaq First North Growth Market Finland - Mar 08, 2021